规范治疗急性尿潴留的探讨  

Specification of the Treatment of Acute Urinary Retention

作　　者：冀永健[1] 刘鲁东[2] 赵林飞[2] 郭震[2] 赵宁[2] 

机构地区：[1]潍坊医学院外科学教研室,山东潍坊261041 [2]潍坊医学院附属潍坊市人民医院,山东潍坊261041

出　　处：《现代临床医学》2010年第1期25-26,共2页Journal of Modern Clinical Medicine

摘　　要：目的:探讨试验性拔管(TWOC)联合α1受体阻滞剂在急性尿潴留中的效果。方法:采用随机对照的原则对采集86例急性尿潴留患者的数据进行分析,在TWOC治疗过程中应用多沙唑嗪与安慰剂治疗和在TWOC成功后,继续应用多沙唑嗪治疗和安慰剂治疗的效果观察。结果:在TWOC治疗过程中应用多沙唑嗪有助于恢复正常排尿(P<0.05);在TWOC成功后,继续应用多沙唑嗪治疗也是有效的(P<0.05)。结论:在TWOC的治疗过程中应用α1受体阻滞剂可提高拔管成功率,能够降低RUR的复发率。Objective：To explore the effect of TWOC withα1-blocker in acute urinary retention.Methods：Random double blind was used to analysis 86 cases of acute urinary retention：In the course of applied TWOC treatment,doxazosin compared with the placebo.After the TWOC was successful,continued to apply Doxazosin,treatment and placebo were observed.Results：It demonstrated that doxazosin intake in TWOC was useful to facilitate and return to normal voiding（P 0.05）;that most patients continued to use doxazosin were available after a successful TWOC（P 0.05）.Conclusion：Treatment with an α1-blocker in TWOC consistently improves the chances of successful catheter drawn,regardless of the duration of catheterization.

关 键 词：急性尿潴留 实验性拔管 Α1受体阻滞剂 前列腺增生 

分 类 号：R694.55[医药卫生—泌尿科学]